Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Parkin coregulated like protein (PACRGL) is a protein encoded by the PACRGL gene (also formerly known as C4orf28 and MGC29898)[1][2][5]. Its precise biological function is not well-characterized in current literature. It is annotated as a conserved protein with \"binding\" activity, but there is no information supporting its role as a receptor, enzyme, or other typical drug target[1][3][7]. No known disease associations, drug interactions, or therapeutic applications are documented as of the available information. Key context: - PACRGL is an *uncharacterized, conserved protein* with limited functional data and is not currently considered a validated therapeutic target in drug discovery or clinical literature[1][3][7]. - No reliable evidence links PACRGL to any specific disease states, drug mechanisms, or safety liabilities based on current databases and protein annotation resources.
None reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parkin coregulated like protein (PACRGL).